证券代码：002836 证券简称：新宏泽 公告编号：2025-008 广东新宏泽包装股份有限公司 股票交易异常波动公告 广东新宏泽包装股份有限公司（证券简称：新宏泽；证券代码：002836， 以下简称"公司"或"本公司"）股票于 2025 年 4 月 17 日、2025 年 4 月 18 日连续 2 个交易日收盘价格涨幅偏离值累计达到 20%，根据《深圳证券交易所 交易规则》的相关规定，属于股票交易异常波动的情况。 二、公司关注并核实的相关情况说明 针对公司股票交易异常波动，公司对有关事项进行了核查，并对控股股东 及实际控制人就相关事项进行了核实，现就有关情况说明如下： 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 1、公司前期所披露的信息不存在需要更正、补充之处。 2、公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较 大影响的未公开重大信息。 3、公司经营情况及内外部经营环境未发生重大变化。 4、经公司自查和问询控股股东和实际控制人，公司、控股股东和实际控制 人不存在关于公司的应披露而未披露的重大事项，或处于筹 ...

4月18日，市场收盘共67股涨停，32股封板未遂，整体封板率为67.68%。 涨停战场： 近60万手买单抢筹新宏泽（维权） 据证券时报·数据宝统计，从收盘涨停板封单量来看，新宏泽封单量最高，达59.83万手；其次是我爱我家、保税科技，涨停板封单 量分别为37.05万手、29.15万手。 以封单金额计算，14股封单金额超亿元，新宏泽、立方制药、海能达等涨停板封单资金最多，分别有5.8亿元、2.84亿元、2.03亿 元。 连续涨停天数来看，国光连锁5连板，立方制药、红宝丽、亚联机械等4连板，特力Ａ、天保基建3连板，国芳集团11日10板、ST柯 利达7日6板、*ST龙宇（维权）5日4板。 | | | | | | | 4月18日封甲资金居前的涨停股 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 代码 | 简称 | 收盘价 | 换手率 | 涨停板封单 | 封审资等 | 连权大 | 涨停原因 | | | | (元) | (%) | (万手) | (1/70) | 散 | | | 002836 | 新宏泽 | 9.69 | 1.11 | 59.83 | 5. ...

Market Overview - The Shanghai Composite Index closed at 3280.34 points, up 0.13%, while the Shenzhen Component Index closed at 9759.05 points, down 0.16% [2] - The ChiNext Index rose by 0.09%, and the Sci-Tech 50 Index increased by 0.23% [2] - Among the tradable A-shares, 3126 stocks rose, accounting for 57.95%, while 2039 stocks fell, and 229 stocks remained flat [2] Stock Performance - A total of 100 stocks hit the daily limit up, while 12 stocks hit the limit down [2] - The leading sectors for limit-up stocks included basic chemicals, light industry manufacturing, and retail, with 14, 8, and 8 stocks respectively [2] - Notably, 14 of the limit-up stocks were ST (special treatment) stocks, including *ST Gongzhi and *ST Hengli [2] Trading Activity - Stocks with the highest limit-up trading volume included Nanji E-commerce with 3168.77 million shares, followed by Xinhongze and Hongbaoli with 3131.60 million and 2045.72 million shares respectively [2] - In terms of trading volume, the stocks with the highest limit-up funds were Tuo Wei Information, Xinhongze, and Lifang Pharmaceutical, with amounts of 4.25 billion, 2.76 billion, and 2.41 billion respectively [2] Detailed Stock List - Tuo Wei Information (002261) closed at 28.38 yuan with a turnover rate of 12.41% and a limit-up volume of 1496.80 million shares [3] - Xinhongze (002836) closed at 8.81 yuan with a turnover rate of 3.03% and a limit-up volume of 3131.60 million shares [3] - Lifang Pharmaceutical (003020) closed at 25.31 yuan with a turnover rate of 1.01% and a limit-up volume of 953.20 million shares [3] - Other notable stocks include Hongbaoli (002165), Nanji E-commerce (002127), and Blue Science and Technology (601798) with significant trading volumes and funds [3][4]

Financial Performance - Total revenue for 2024 reached CNY 366,961,875.76, a year-on-year increase of 107.19%[4] - Net profit attributable to shareholders was CNY 62,497,180.07, reflecting a growth of 220.99% compared to the previous year[4] - Net profit after deducting non-recurring gains and losses was CNY 59,100,931.28, an increase of 297.39% year-on-year[4] - Basic earnings per share rose to CNY 0.28, representing a 250% increase from the previous year[4] - Operating profit for the period was CNY 71,954,940.38, up 203.17% year-on-year[4] Assets and Returns - Total assets at the end of the reporting period were CNY 531,628,129.09, a 10.94% increase from the beginning of the period[4] - The weighted average return on equity was 17.40%, up from 4.85% in the previous year, an increase of 12.55%[4] Market Opportunities - The company capitalized on market opportunities in the tobacco label industry, leading to increased sales orders and operational efficiency[5] Reporting Accuracy - There were no discrepancies between the reported performance and the previously announced earnings forecast[6] - The financial data presented is preliminary and subject to change upon final audit[7]

Financial Performance - The estimated net profit attributable to shareholders for Q1 2025 is projected to be between 15.35 million and 19.59 million yuan, representing a year-on-year growth of 45.00% to 85.00%[3] - The estimated net profit after deducting non-recurring gains and losses is projected to be between 14.66 million and 18.57 million yuan, indicating a year-on-year growth of 50.00% to 90.00%[3] - The basic earnings per share is expected to be between 0.07 and 0.09 yuan, compared to 0.05 yuan in the same period last year[3] Business Operations - The significant increase in orders is attributed to the company's active participation in new tobacco packaging bidding activities, leading to substantial growth in both revenue and net profit[5] Disclosure and Compliance - The financial data in the earnings forecast has not been audited by an accounting firm[4] - The company emphasizes the importance of timely and accurate information disclosure to investors, urging them to be cautious and aware of investment risks[7]

Core Viewpoint - The company Xin Hong Ze (002836) reported significant growth in its financial performance for the fiscal year 2024, indicating strong operational efficiency and profitability [1] Financial Performance Summary - The total operating revenue for 2024 reached 367 million yuan, representing a year-on-year increase of 107.19% [1] - The net profit attributable to shareholders of the listed company was 62.497 million yuan, showing a year-on-year growth of 220.99% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 59.101 million yuan, reflecting a substantial year-on-year increase of 297.39% [1] - The basic earnings per share were 0.28 yuan, which is a year-on-year increase of 250.00% [1] - The weighted average return on equity was 17.40%, up by 12.55% compared to the previous year [1]

广东新宏泽包装股份有限公司 关于公司产线升级改造项目的公告 证券代码：002836 证券简称：新宏泽 公告编号：2025-005 广东新宏泽包装股份有限公司（以下简称"公司"）根据市场需求及公司实 际情况，为提高生产产能，持续提升产品质量、产线自动化及信息化程度，拟进 行产线升级改造，本次产线升级改造基本情况如下： 公司计划以自有资金投入 6,000 万元对现有产线进行升级改造，其中厂房改 扩建拟投入 1,200 万元，设备更新采购拟投入 4,800 万元。该项目预计 2025 年 12 月改造完成，具体事务由公司管理层或总经理决定实施。 二、审议程序 公司于2025年2月18日召开第五届董事会第十三次会议，审议通过了《关于 公司产线升级改造项目的议案》，表决结果：7票同意，0票反对，0票弃权。 本次投资事项全部以自有资金投入，不构成关联交易，不构成《上市公司重 大资产重组管理办法》规定的重大资产重组，在董事会审议权限内，无需提交公 司股东大会审议。 三、项目投资的目的及对公司的影响 通过本次产线改造升级，能更好地满足客户对高品质产品的要求、更高效 地承接公司生产计划与产能，并进一步提升智能制造水平，实现降本 ...

证券代码：002836 证券简称：新宏泽 公告编号：2025-004 广东新宏泽包装股份有限公司 第五届董事会第十三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 （一）审议通过《关于公司产线升级改造项目的议案》 同意公司以自有资金投入 6,000 万元对现有产线进行升级改造，其中厂房改 扩建拟投入 1,200 万元，设备更新采购拟投入 4,800 万元。该项目预计 2025 年 12 月改造完成，具体事务由公司管理层或总经理决定实施。 表决结果：7 票同意，0 票反对，0 票弃权。 具体内容请见公司同日在《证券时报》、《中国证券报》、《上海证券 部》、《证券日报》和巨潮资讯网上披露的《关于公司产线升级改造项目的公 告》（公告编号：2025-005）。 特此公告。 1/2 广东新宏泽包装股份有限公司董事会 一、董事会会议召开情况 广东新宏泽包装股份有限公司（以下简称"公司"）第五届董事会第十三次 会议于 2025 年 2 月 18 日以通讯表决的方式召开。会议通知于 2025 年 2 月 12 日 通过邮件、专人送达、通讯等方式送达各位董事。本 ...

证券时报网讯，新宏泽（002836）1月20日发布2024年业绩预增公告，预计实现净利润为5900.00万元 ~7300.00万元，净利润同比增长203.03%~274.94%。 证券时报•数据宝统计显示，新宏泽今日收于7.78元，下跌6.04%，日换手率为8.46%，成交额为1.59亿 元，近5日上涨3.05%。 预告发布后5日股价上涨的占比83.33%。 通过对2024年业绩预增50%以上的个股走势进行统计发现，预告发布后当日股价上涨的占比71.30%，股 价发布当日股价涨停的有16家。 ...

Financial Projections - The estimated net profit attributable to shareholders for 2024 is projected to be between 59 million and 73 million yuan, representing a year-on-year increase of 203.03% to 274.94% compared to 19.47 million yuan in the previous year[3]. - The estimated net profit after deducting non-recurring gains and losses is expected to be between 55 million and 69 million yuan, indicating a growth of 269.81% to 363.95% from 14.87 million yuan in the same period last year[3]. - The basic earnings per share is forecasted to be between 0.26 and 0.32 yuan per share, up from 0.08 yuan per share in the previous year[3]. Revenue and Profit Drivers - The significant increase in revenue and net profit is attributed to the company's deepening involvement in the tobacco packaging sector and successful participation in new tobacco packaging tenders from various tobacco companies[5]. Financial Reporting and Compliance - The financial data in the earnings forecast has not been audited by the accounting firm, but there are no significant discrepancies between the company and the accounting firm regarding the earnings forecast[4]. - The company emphasizes the importance of timely and accurate information disclosure in accordance with relevant laws and regulations, urging investors to be cautious and aware of investment risks[7].